Leading a New Era in Lung Cancer Treatment and Survival

October 2014
Orange County Business Journal;10/27/2014, Vol. 37 Issue 43, p48
The article discusses aspects on the treatment of lung cancer and patient outcomes at the University of California (UC)-Irvine Health Chao Family Comprehensive Cancer Center emphasizing on targeted medications and the minimally invasive lung surgery.


Related Articles

  • Pioneering Therapy Extends Life of Lung Cancer Patient.  // Orange County Business Journal;5/19/2014, Vol. 37 Issue 20, p48 

    The article focuses on cancer survivor Jackie Raser, who enrolled in the clinical trials which were conducted by doctor Ignatius Ou, University of California (UC) Irvine Health oncologist, at the Chao Family Comprehensive Cancer Center to treat her non-small cell lung cancer.

  • Lung Cancer Screening Targets Deadliest Cancer.  // Orange County Business Journal;5/19/2014, Vol. 37 Issue 20, p48 

    The article offers information on the University of California (UC) Irvine Health which offers lung cancer screening to individuals who are considered at high risk for lung cancer using low-dose computed tomography (CT). Topics discussed include chief of the Division of Pulmonary & Critical Care...

  • Impact of FDG-PET-Induced Treatment Choices on Long-Term Outcome in Non-Small Cell Lung Cancer. Wauters, Isabelle; Stroobants, Sigrid; De Leyn, Paul; d'Hoore, Isabelle; Nackaerts, Kris; Dooms, Christophe; Vansteenkiste, Johan // Respiration;2010, Vol. 79 Issue 2, p97 

    Background: The TNM staging reflects the anatomic extent of lung cancer and estimates the survival expectation. Addition of FDG-PET to conventional staging (CS) improves accuracy, but few data have described the impact of this on long-term survival in relation to treatment. Objectives: To study...

  • The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study. Agarwal, Rishi; Saluja, Paramveer; Pham, Angela; Ledbetter, Karen; Bains, Sukhveer; Varghese, Seema; Clements, John; Kim, Young H. // Cancer Management & Research;2012 Part 2, Vol. 4, p347 

    Introduction: The current standard for treating operable early stage non-small cell lung cancer is surgical resection and for inoperable cases it is external beam radiotherapy. Lung functions are adversely affected with both the above treatments. CyberKnife treatment limits radiation damage by...

  • Lung surgery for metastatic epithelial tumours. Kycler, Witold; Kubiak, Anna; Laski, Piotr; Cybulski, Zefiryn; Perz, Hanna // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2015, Vol. 69, p277 

    Introduction: The aim of this study is to evaluate outcomes following the surgical treatment of pulmonary metastases in patients with different types of epithelial cancers, as well as to identify prognostic factors after metastasectomy. Material/Methods: We retrospectively reviewed data for 61...

  • The Relationship between Patient Satisfaction with Service Quality and Survival in Non-Small Cell Lung Cancer – Is Self-Rated Health a Potential Confounder? Lis, Christopher G.; Patel, Kamal; Gupta, Digant // PLoS ONE;7/31/2015, Vol. 10 Issue 7, p1 

    Background/Aims: Previously we reported that higher patient satisfaction (PS) with service quality is associated with favorable survival outcomes in a variety of cancers. However, we cautioned the readers that patients with greater satisfaction might be the ones with better self-rated health...

  • Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients. Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Tresch, Emmanuelle; Reynaert, Nick; Lartigau, Eric // PLoS ONE;7/24/2015, Vol. 10 Issue 7, p1 

    Purpose: SBRT is the standard of care for inoperable patients with early-stage lung cancer without lymph node involvement. Excellent local control rates have been reported in a large number of series. However, prescription doses and calculation algorithms vary to a great extent between studies,...

  • The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy. Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Yuan, Zheng; Lin, Dong-Mei; Li, Dan; Zhou, Yu-Jie; Lin, Hua; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: This study aimed to elucidate clinical significance of anaplastic lymphoma kinase (ALK) rearrangement in selected advanced non-small cell lung cancer (NSCLC), to compare the application of different ALK detection methods, and especially evaluate a possible association between ALK...

  • Implementing Direct Access to Low-Dose Computed Tomography in General Practice—Method, Adaption and Outcome. Guldbrandt, Louise Mahncke; Rasmussen, Torben Riis; Rasmussen, Finn; Vedsted, Peter // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Background: Early detection of lung cancer is crucial as the prognosis depends on the disease stage. Chest radiographs has been the principal diagnostic tool for general practitioners (GPs), but implies a potential risk of false negative results, while computed tomography (CT) has a higher...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics